RECURSION PHARMACEUTICALS IN

Historical 13F Holders

CUSIP
75629V904

Looks like an option CUSIP for calls on RXRX (75629V104). The SEC asks managers to report options under the underlying security's CUSIP instead.

All holders as of
Q2 2026
Type
Equity
Class
CALL
Reported Value, Excluding Options
Total Filings

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 5 297 k $1.09 M
2026 Q1 4 93.4 k $286 k
2025 Q4 4 0 $0
2025 Q3 5 0 $0
2025 Q2 6 0 $0
2025 Q1 5 0 $0
2024 Q4 3 0 $0
2024 Q3 3 0 $0
2024 Q2 4 0 $0
2024 Q1 4 0 $0
2023 Q4 4 0 $0
2023 Q3 4 0 $0
2023 Q2 4 0 $0
2023 Q1 4 0 $0
2022 Q4 3 0 $0
2022 Q3 3 0 $0
2022 Q2 2 0 $0
2022 Q1 2 0 $0
2021 Q4 3 0 $0
2021 Q3 2 0 $0
2021 Q2 1 0 $0